Juvenescence Appoints Dr Richard Marshall CBE as CEO
Juvenescence is a life sciences company developing therapies to modify aging and increase healthy human lifespan.
Juvenescence’s Latest Venture, MDI Therapeutics, Inc., Targeting Fibrotic Disease
A biopharmaceutical company focused on treating aging and age-related disease
Juvenescence Confirms Close of Souvien Therapeutics and Announces High-level Appointments
Juvenescence is pleased to announce its latest biotech company Souvien Therapeutics (“Souvien”), creating innovative medicines to address neurodegenerative diseases by targeting the epigenetic underpinnings of neurodegeneration.
Juvenescence Capitalizes BYOMass
Juvenescence is pleased to announce its latest equity investment in BYOMass Inc.
Juvenescence, The Buck Institute, and Insilico Medicine establish Napa Therapeutics
The Buck Institute is one of the leading research centers in the world focused solely on research on aging and the elimination of age-related disease.